scholarly journals MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments

2011 ◽  
Vol 13 (5) ◽  
Author(s):  
Heleen Scheerens ◽  
Zheng Su ◽  
Bryan Irving ◽  
Michael J Townsend ◽  
Yanan Zheng ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

A randomized, double-blind, placebo-controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

1995 ◽  
Vol 38 (8) ◽  
pp. 1097-1106 ◽  
Author(s):  
Peter A. Van Der Lubbe ◽  
Ben A. C. Dijkmans ◽  
Hendrik M. Markusse ◽  
Ulla Nässander ◽  
Ferdinand C. Breedveld
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Early Rheumatoid Arthritis ◽  
Antibody Therapy ◽  
Controlled Study ◽  
Monoclonal Antibody Therapy ◽  
Double Blind ◽  
Double Blind Placebo

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

2004 ◽  
Vol 171 (4S) ◽  
pp. 234-234 ◽  
Author(s):  
Harin Padma-Nathan ◽  
Jae Seung Pacik ◽  
Byoung Ok Ahn ◽  
Kyung Koo Kang ◽  
Mi Young Bahng ◽  
...  
Keyword(s):  
Phase I ◽  
Controlled Study ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Male Subjects
Sign in / Sign up

Export Citation Format

Share Document